<DOC>
	<DOCNO>NCT00434616</DOCNO>
	<brief_summary>Critical limb ischemia condition blood circulation limb , case legs , decrease pain non heal wound ensue . Mostly , sequel arteriosclerosis and/or diabetes . If surgical method improvement blood supply leg fail possible , patient proceed amputation leg . Bone marrow contain cell induce augment growth new , small artery call collateral artery . It show animal case series transplantation concentrate patient 's bone marrow stem cell ischemic limb improve blood circulation via induction collateral growth . However , know bone-marrow stem cell induce collateral growth sufficient avoid otherwise necessary amputation . Therefore , conduct study compare efficiency concentrate bone marrow cell inject critically ischemic limb compare placebo procedure saline inject . We think transplantation autologous bone marrow reduce number necessary leg amputation , reduce pain induce wound heal . In investigation , patient limb threaten ischemia randomly allocate either bone marrow group placebo group . Patients bone marrow group bone marrow harvest sedation , bone marrow cell concentrate . The cell concentrate inject directly muscle diseased leg . Patients placebo group undergo sedation well bone marrow harvest do , saline inject ischemic leg . The procedure require 1.5-2 hour , subject admit participate vascular Centre . Monthly examination three month bone-marrow placebo procedure do . After follow-up three month , rate death amputation wound heal process compare group . Adverse serious adverse event record time period . Diagnostic study obtain measure blood flow treat leg follow period include skin oxygen measurement , pressure recording leg arteriography . Also , quality life , pain wound heal assess . After completion three month study participation , subject treat placebo able receive open-label bone marrow transplantation therapy .</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cell Transplantation Critical , Limb-threatening Ischemia</brief_title>
	<detailed_description>Peripheral arterial disease ( PAD ) represent advanced arteriosclerosis . It unusual condition result limb-threatening ischemia usually result amputation limb . About 150.000 thigh calf amputation due PAD do annually United state . Treatment critical limb threaten ischemia ( correspond Rutherford grade II III ) consist revascularization leg critically reduce blood supply . Depending localization morphology occlusion , surgical revascularization mean bypass surgery catheter-based percutaneous transluminal angioplasty ( PTA ) may use ( even complementary procedure ) . However , successful revascularization possible max . 60 % 70 % patient affected . Patients limb threaten ischemia revascularized one-year amputation rate exceed 80 % 20-30 % mortality . Several study show less advanced PAD implantation concentration mononuclear cell harvest patient 's bone marrow effective develop collateral vessel formation translate improvement PAD symptom . Additional clinical evidence simple , safe inexpensive therapy induce therapeutic angiogenesis ischemic limb sufficient prevent amputation would valuable patient clinician . This study evaluate clinical potential implantation concentration bone marrow mononuclear cell contain stem cell therapeutic angiogenesis augment formation collateral vessel ischemic limb . It placebo-controlled , 1:1 randomize study total 90 patient include . The placebo procedure consist sham bone marrow puncture bone marrow aspiration do ; instead , stab puncture skin make . The bone marrow cell concentrate prepare `` point care '' , patient-side aspirate 240 mL bone marrow . A concentrate volume 40-50 mL inject 40-50 site muscle ischemic limb . A blinded physician inject either bone marrow cell concentrate visually identical placebo solution ischemic leg . Improvement perfusion limb measure use clinical assessment ankle-brachial-index ( ABI ) , transcutaneous oxygen ( TcPO2 ) contrast angiography . Quality life pain assess . Study participation end subject follow-up three month monthly visit . After , clinical perfusion status record least three-monthly two year study inclusion . HYPOTHESIS : Implantation Bone Marrow stem cell Aspirate Concentrate ( BMAC ) clinically effective treat critical limb threaten ischemia number amputation reduce . Inclusion criterion : - Presence Critical Limb ischemia accord guideline Transatlantic Consensus Group ( TASC ) Rutherford grade II III . Perfusion measure absolute perfusion pressure ankle-brachial index ( ABI ) transcutaneous oxygen tension ( TcpO2 ) ; inclusion , ABI le equal 0.6 absolute ankle pressure must less 60 mmHg . If ABI technically feasible , e.g . patient medium calcification , inclusion criterion tcpO2 value ( supine , forefoot , 44°C ) less 20 mmHg tissue loss , tcpO2 less 40 mmHg tissue loss . - No sufficient response best standard care deliver six week . - No surgical radiological interventional option revascularisation confirm vascular surgeon interventional radiologist - Age old 18 year - Signed informed consent - Absence life-threatening complication ischemic limb Exclusion criterion : - Expected life span less six month - Bone marrow disease preclude transplantation ( eg lymphoma , leukemia , myelodysplastic syndrome others ) - Renal failure hemodialysis - Life threaten complication limb ischemia need immediate limb amputation avoid death clinical deterioration End point : - Primary end point : Major amputation ( ankle ) index limb 3 month persist critical limb ischemia index limb three month - Secondary end point : - Wound heal ( wound size , wound stage ) - Pain analgesic use - Rutherford grade stage - Walking distance ( treadmill ) possible - Quality life ( EQ-5D Questionnaire ) - Transcutaneous oxygen pressure ( TcpO2 ) , ABI , absolute ankle perfusion pressure - Collateral artery number judge contrast angiography 3 month - Rate extent minor ( ankle ) amputation index limb</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Gangrene</mesh_term>
	<criteria>Presence Critical Limb ischemia accord guideline Transatlantic Consensus Group ( TASC ) Rutherford grade II III . Perfusion measure absolute perfusion pressure anklebrachial index ( ABI ) transcutaneous oxygen tension ( TcpO2 ) ; inclusion , ABI le equal 0.6 absolute ankle pressure must less 60 mmHg . If ABI technically feasible , e.g . patient medium calcification , inclusion criterion tcpO2 value ( supine , forefoot , 44°C ) less 20 mmHg tissue loss , tcpO2 less 40 mmHg tissue loss . No sufficient response best standard care deliver six week . No surgical radiological interventional option revascularisation confirm vascular surgeon interventional radiologist Age old 18 year Signed informed consent Absence lifethreatening complication ischemic limb Expected life span less six month Bone marrow disease preclude transplantation ( eg lymphoma , leukaemia , myelodysplastic syndrome others ) Renal failure hemodialysis Life threaten complication limb ischemia need immediate limb amputation avoid death clinical deterioration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>angiogenesis</keyword>
	<keyword>Arterial Occlusive Diseases</keyword>
	<keyword>Leg Ulcer</keyword>
	<keyword>Gangrene</keyword>
	<keyword>Ischemia</keyword>
	<keyword>PAOD</keyword>
	<keyword>Amputation</keyword>
	<keyword>bone marrow</keyword>
</DOC>